CYTK's logo.
Ticker Symbol: CYTK

Cytokinetics Inc

$39.24 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001061983

Company Profile

Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 280 E Grand Ave
CEO: Robert Blum
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $26.88
Change: -$1.00 ( -3.59%)
Days Range: $26.57 - $28.17
Beta: -
52wk. High: $47.64
52wk. Low: $25.98
Ytd. Change -42.74%
50 Day Moving Average: $32.59
200 Day Moving Average: $34.77
Shares Outstanding: 95997998

Valuation

Market Cap: 258.0B
PE Ratio: -4.72
EPS (TTM): -5.69

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A